title: Utilization of serologic assays to support efficacy of vaccines in nonclinical and clinical trials: meeting at the crossroads.
abstract: In May 2009 the National Institute of Allergy and Infectious Diseases hosted a workshop on serologic assays that support vaccine efficacy evaluations. The meeting promoted exchange of ideas among investigators from varying disciplines who are working on anti-infectious agent vaccines at different stages of development. The presentations and discussions at the workshop illustrated the challenges common across various pathogens with recurring themes: (1) A thorough understanding of the science regarding the pathogen and the host response to disease and immunization is fundamental to assay selection. (2) The intended use of the immunoassay data must be clearly defined to ensure appropriate specificity, accuracy, and precision; a laboratory must also commit resources to assure data quality and reliability. (3) During vaccine development, an immunoassay may evolve with respect to quality, purpose, and degree of standardization, and, in some cases, must be changed or replaced as data are accumulated. (4) Collaboration on standardized reagents and methods, harmonization efforts, and multidisciplinary teams facilitate consistent generation of quality data. This report provides guidance for effective development and utilization of immunoassays based on the lessons learned from currently licensed vaccines. Investigators are encouraged to create additional opportunities for scientific exchange, noting that the discussed themes are relevant for immunoassays used for other purposes such as therapeutics and diagnostics.
authors.affiliation: Madore Medical Writing, LLC, Pittsford, NY 14534, USA.
authors.forename: Dace V
authors.initials: DV
authors.lastname: Madore
authors.forename: Bruce D
authors.initials: BD
authors.lastname: Meade
authors.forename: Fran
authors.initials: F
authors.lastname: Rubin
authors.forename: Carolyn
authors.initials: C
authors.lastname: Deal
authors.forename: Freyja
authors.initials: F
authors.lastname: Lynn
mesh_terms: D007118:Immunoassay / Q000592:standards* / Q000706:statistics & numerical data*; D014612:Vaccines / Q000032:analysis* / Q000276:immunology*
chemical_list: D014612:Vaccines
references.citation: Infect Immun. 2004 Oct;72(10):5903-9
references.pmid: 15385492
references.citation: Infection. 1984;12 Suppl 1:S44-51
references.pmid: 6397449
references.citation: Clin Microbiol Rev. 1995 Jan;8(1):22-33
references.pmid: 7704893
references.citation: J Virol Methods. 2008 Oct;153(1):43-8
references.pmid: 18634828
references.citation: Clin Infect Dis. 2005 Oct 15;41(8):1150-6
references.pmid: 16163634
references.citation: Vaccine. 2007 Sep 28;25(39-40):6852-62
references.pmid: 17719149
references.citation: Scand J Infect Dis. 1978;10(1):41-4
references.pmid: 635475
references.citation: Hum Vaccin. 2008 Nov-Dec;4(6):444-8
references.pmid: 18728401
references.citation: Infect Immun. 2003 Jan;71(1):275-86
references.pmid: 12496177
references.citation: J Virol. 2008 Mar;82(5):2350-7
references.pmid: 18094185
references.citation: Clin Diagn Lab Immunol. 1998 Jul;5(4):479-85
references.pmid: 9665952
references.citation: Cancer Immunol Immunother. 2009 Oct;58(10):1701-13
references.pmid: 19259668
references.citation: Lancet. 1986 Feb 8;1(8476):307-10
references.pmid: 2868172
references.citation: Immunol Invest. 2001 Aug;30(3):191-207
references.pmid: 11570640
references.citation: Vaccine. 2008 Jun 25;26(27-28):3516-21
references.pmid: 18495303
references.citation: Nat Rev Microbiol. 2006 Dec;4(12):932-42
references.pmid: 17088932
references.citation: J Immunol. 1971 Oct;107(4):1081-9
references.pmid: 5315273
references.citation: J Infect Dis. 1992 Mar;165(3):456-63
references.pmid: 1538152
references.citation: Vaccine. 2007 May 10;25(19):3816-26
references.pmid: 17368878
references.citation: Clin Diagn Lab Immunol. 2003 Jul;10(4):514-9
references.pmid: 12853378
references.citation: Infect Immun. 1999 Aug;67(8):4303-5
references.pmid: 10447392
references.citation: J Clin Microbiol. 2000 Jun;38(6):2043-50
references.pmid: 10834951
references.citation: Intervirology. 2007;50(1):58-62
references.pmid: 17164559
references.citation: Curr Infect Dis Rep. 2008 May;10(3):192-9
references.pmid: 18510880
references.citation: Epidemiol Infect. 2009 Dec;137(12):1684-6
references.pmid: 19366492
references.citation: Health Aff (Millwood). 2005 Jan-Feb;24(1):67-78
references.pmid: 15647217
references.citation: J Infect Dis. 2009 Jan 1;199(1):108-15
references.pmid: 19086816
references.citation: Clin Vaccine Immunol. 2009 Mar;16(3):303-11
references.pmid: 19109448
references.citation: Dev Biol Stand. 1998;95:221-2
references.pmid: 9855435
references.citation: Expert Rev Vaccines. 2005 Apr;4(2):207-18
references.pmid: 15889994
references.citation: Vaccine. 2007 May 16;25(20):4056-63
references.pmid: 17412461
references.citation: Vaccine. 2008 Sep 12;26 Suppl 4:D41-4
references.pmid: 19230158
references.citation: Clin Chem. 1979 Mar;25(3):432-8
references.pmid: 262186
references.citation: Biologicals. 2007 Jun;35(3):183-7
references.pmid: 17241789
references.citation: Clin Vaccine Immunol. 2006 Sep;13(9):1004-9
references.pmid: 16960111
references.citation: Stat Methods Med Res. 1999 Jun;8(2):135-60
references.pmid: 10501650
references.citation: PDA J Pharm Sci Technol. 1998 Mar-Apr;52(2):55-9
references.pmid: 9610168
references.citation: J Infect Dis. 1986 Jan;153(1):8-16
references.pmid: 3484506
references.citation: N Engl J Med. 1987 Oct 8;317(15):923-9
references.pmid: 2442610
references.citation: Pediatrics. 1999 Oct;104(4 Pt 1):942-50
references.pmid: 10506239
references.citation: Clin Chem. 1993 Mar;39(3):424-32
references.pmid: 8448852
references.citation: Pediatr Infect Dis J. 2000 Mar;19(3):187-95
references.pmid: 10749457
references.citation: J Virol. 2007 Sep;81(17):9443-50
references.pmid: 17596309
references.citation: Vaccine. 2008 Jul 18;26 Suppl 3:C8-14
references.pmid: 18773534
references.citation: J Clin Invest. 1973 Aug;52(8):1885-92
references.pmid: 4719668
references.citation: J Infect Dis. 2000 Nov;182(5):1331-42
references.pmid: 11010838
references.citation: J Transl Med. 2010 Mar 16;8:26
references.pmid: 20233418
references.citation: Vaccine. 2003 Sep 8;21(25-26):3542-9
references.pmid: 12922081
references.citation: Clin Diagn Lab Immunol. 2001 May;8(3):616-23
references.pmid: 11329468
references.citation: Vaccine. 2003 Jul 28;21(24):3479-82
references.pmid: 12850364
references.citation: Vaccine. 2009 Jun 24;27 Suppl 2:B112-6
references.pmid: 19464093
references.citation: Pediatrics. 1977 Nov;60(5):730-7
references.pmid: 335348
references.citation: Cancer Immunol Immunother. 2008 Mar;57(3):303-15
references.pmid: 17721781
references.citation: J Infect Dis. 1977 Aug;136 Suppl:S38-42
references.pmid: 19543
references.citation: J Immunol. 1971 Jul;107(1):123-30
references.pmid: 5091954
references.citation: Dev Biol (Basel). 2003;115:63-73
references.pmid: 15088777
references.citation: Pediatr Infect Dis J. 1997 Sep;16(9):913-4
references.pmid: 9306493
references.citation: Biologics. 2008 Sep;2(3):433-9
references.pmid: 19707374
references.citation: Pediatrics. 1995 Sep;96(3 Pt 2):570-5
references.pmid: 7659478
references.citation: Vaccine. 2003 Jul 4;21(23):3265-72
references.pmid: 12804857
references.citation: J Infect Dis. 1992 Jun;165 Suppl 1:S129-33
references.pmid: 1588146
references.citation: Infect Immun. 2001 Mar;69(3):1568-73
references.pmid: 11179328
references.citation: AMA Am J Dis Child. 1953 Sep;86(3):347-8
references.pmid: 13091327
references.citation: J Exp Med. 1969 Jun 1;129(6):1307-26
references.pmid: 4977280
references.citation: J Med Virol. 1989 Feb;27(2):124-30
references.pmid: 2466102
references.citation: Dev Biol (Basel). 2004;116:61-6; discussion 69-76
references.pmid: 15603184
references.citation: Clin Diagn Lab Immunol. 1996 Nov;3(6):689-700
references.pmid: 8914760
references.citation: Clin Diagn Lab Immunol. 1995 Sep;2(5):590-7
references.pmid: 8548539
references.citation: J Infect Dis. 2007 Nov 1;196(9):1304-12
references.pmid: 17922394
references.citation: J Infect Dis. 1983 Jun;147(6):1100
references.pmid: 6602191
references.citation: Vaccine. 1998 Dec;16(20):1907-16
references.pmid: 9796042
references.citation: J Clin Virol. 2008 Sep;43(1):73-8
references.pmid: 18571465
references.citation: Stat Med. 2008 Oct 15;27(23):4758-78
references.pmid: 17979212
references.citation: Clin Diagn Lab Immunol. 1997 Mar;4(2):156-67
references.pmid: 9067649
references.citation: Clin Microbiol Rev. 2005 Jan;18(1):102-27
references.pmid: 15653821
references.citation: Pediatr Infect Dis J. 2004 Sep;23(9):852-6
references.pmid: 15361726
references.citation: Vaccine. 2009 Jun 24;27 Suppl 2:B117-25
references.pmid: 19477054
references.citation: J Infect Dis. 2004 Jul 15;190(2):373-8
references.pmid: 15216475
references.citation: Vaccine. 2009 Feb 5;27(6):803-14
references.pmid: 19071179
references.citation: Vaccine. 1998 Dec;16(20):1901-6
references.pmid: 9796041
references.citation: Clin Vaccine Immunol. 2009 Oct;16(10):1405-12
references.pmid: 19656993